The DOI matches its OpenAlex record; 87 of the 87 references it cites were found in a registry or an index.
2015 update of the drug resistance mutations in HIV-1
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,469
Self-citationUPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1
&NA; (2001) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200106000-00020 · Cited by 1,660
Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Günthard, H. F., Saag, M. S., Benson, C. A., del Rio, C., Eron, J. J., Gallant, J. E., Hoy, J. F., Mugavero, M. J., Sax, P. E., Thompson, M. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.8900 · Cited by 656
Self-citationHirsch, M. S., Günthard, H. F., Schapiro, J. M., Brun‐Vézinet, F., Clotet, B., Hammer, S. M., Johnson, V. A., Kuritzkes, D. R., Mellors, J. W., Pillay, D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/589297 · Cited by 573
Self-citationRaffi, F., Rachlis, A., Stellbrink, H.-J., Hardy, W. D., Torti, C., Orkin, C., Bloch, M., Podzamczer, D., Pokrovsky, V., Pulido, F., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61853-4 · Cited by 548
Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection
Cooper, D. A., Steigbigel, R. T., Gatell, J. M., Rockstroh, J. K., Katlama, C., Yeni, P., Lazzarin, A., Clotet, B., Kumar, P. N., Eron, J. E., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708978 · Cited by 509
Saag, M. S., Gandhi, R. T., Hoy, J. F., Landovitz, R. J., Thompson, M. A., Sax, P. E., Smith, D. M., Benson, C. A., Buchbinder, S. P., del Rio, C., et al. (2020) · JAMA · doi:10.1001/jama.2020.17025 · Cited by 471
Self-citationSax, P. E., DeJesus, E., Mills, A., Zolopa, A., Cohen, C., Wohl, D., Gallant, J. E., Liu, H. C., Zhong, L., Yale, K., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60917-9 · Cited by 444
Clinical targeting of HIV capsid protein with a long-acting small molecule
Link, J. O., Rhee, M. S., Tse, W. C., Zheng, J., Somoza, J. R., Rowe, W., Begley, R., Chiu, A., Mulato, A., Hansen, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2443-1 · Cited by 425
Kellam, P., Boucher, C. A., & Larder, B. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1934 · Cited by 413
Molina, J.-M., Cahn, P., Grinsztejn, B., Lazzarin, A., Mills, A., Saag, M., Supparatpinyo, K., Walmsley, S., Crauwels, H., Rimsky, L. T., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60936-7 · Cited by 405
Reeves, J. D., Gallo, S. A., Ahmad, N., Miamidian, J. L., Harvey, P. E., Sharron, M., Pöhlmann, S., Sfakianos, J. N., Derdeyn, C. A., Blumenthal, R., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252469399 · Cited by 404
In Vitro Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
Kobayashi, M., Yoshinaga, T., Seki, T., Wakasa-Morimoto, C., Brown, K. W., Ferris, R., Foster, S. A., Hazen, R. J., Miki, S., Suyama-Kagitani, A., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01209-10 · Cited by 382
Overton, E. T., Richmond, G., Rizzardini, G., Jaeger, H., Orrell, C., Nagimova, F., Bredeek, F., García Deltoro, M., Swindells, S., Andrade-Villanueva, J. F., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32666-0 · Cited by 377
Cohen, C. J., Andrade-Villanueva, J., Clotet, B., Fourie, J., Johnson, M. A., Ruxrungtham, K., Wu, H., Zorrilla, C., Crauwels, H., Rimsky, L. T., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60983-5 · Cited by 374
DeJesus, E., Rockstroh, J. K., Henry, K., Molina, J.-M., Gathe, J., Ramanathan, S., Wei, X., Yale, K., Szwarcberg, J., White, K., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60918-0 · Cited by 347
Castagna, A., Maggiolo, F., Penco, G., Wright, D., Mills, A., Grossberg, R., Molina, J.-M., Chas, J., Durant, J., Moreno, S., et al. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu051 · Cited by 333
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection
Segal-Maurer, S., DeJesus, E., Stellbrink, H.-J., Castagna, A., Richmond, G. J., Sinclair, G. I., Siripassorn, K., Ruane, P. J., Berhe, M., Wang, H., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2115542 · Cited by 331
Eron, J. J., Clotet, B., Durant, J., Katlama, C., Kumar, P., Lazzarin, A., Poizot-Martin, I., Richmond, G., Soriano, V., Ait-Khaled, M., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis750 · Cited by 311
Azijn, H., Tirry, I., Vingerhoets, J., de Béthune, M.-P., Kraus, G., Boven, K., Jochmans, D., Van Craenenbroeck, E., Picchio, G., & Rimsky, L. T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00986-09 · Cited by 293
Tsiang, M., Jones, G. S., Goldsmith, J., Mulato, A., Hansen, D., Kan, E., Tsai, L., Bam, R. A., Stepan, G., Stray, K. M., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01474-16 · Cited by 290
Malet, I., Delelis, O., Valantin, M.-A., Montes, B., Soulie, C., Wirden, M., Tchertanov, L., Peytavin, G., Reynes, J., Mouscadet, J.-F., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01228-07 · Cited by 283
Update of the drug resistance mutations in HIV-1: March 2013.
Johnson, V. A., Cálvez, V., Günthard, H. F., Paredes, R., Pillay, D., Shafer, R. W., Wensing, A. M. J., & Richman, D. D. (2013) · Europe PMC (PubMed Central) · Cited by 240
Self-citationPhase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
Emu, B., Fessel, J., Schrader, S., Kumar, P., Richmond, G., Win, S., Weinheimer, S., Marsolais, C., & Lewis, S. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1711460 · Cited by 227
HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture
Brenner, B. G., Oliveira, M., Doualla-Bell, F., Moisi, D. D., Ntemgwa, M., Frankel, F., Essex, M., & Wainberg, M. A. (2006) · AIDS · doi:10.1097/01.aids.0000232228.88511.0b · Cited by 226
HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
Blanco, J.-L., Varghese, V., Rhee, S.-Y., Gatell, J. M., & Shafer, R. W. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir025 · Cited by 218
Self-citationWhitcomb, J. M., Parkin, N. T., Chappey, C., Hellmann, N. S., & Petropoulos, C. J. (2003) · The Journal of Infectious Diseases · doi:10.1086/378281 · Cited by 216
HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
Rhee, S.-Y., Taylor, J., Fessel, W. J., Kaufman, D., Towner, W., Troia, P., Ruane, P., Hellinger, J., Shirvani, V., Zolopa, A., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-10 · Cited by 216
Self-citationGünthard, H. F., Calvez, V., Paredes, R., Pillay, D., Shafer, R. W., Wensing, A. M., Jacobsen, D. M., & Richman, D. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy463 · Cited by 212
Self-citationCutrell, A. G., Schapiro, J. M., Perno, C. F., Kuritzkes, D. R., Quercia, R., Patel, P., Polli, J. W., Dorey, D., Wang, Y., Wu, S., et al. (2021) · AIDS · doi:10.1097/qad.0000000000002883 · Cited by 211
Lenacapavir: a first-in-class HIV-1 capsid inhibitor
Dvory‐Sobol, H., Shaik, M. N., Callebaut, C., & Rhee, M. S. (2021) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000713 · Cited by 189
Vingerhoets, J., Tambuyzer, L., Azijn, H., Hoogstoel, A., Nijs, S., Peeters, M., de Béthune, M.-P., De Smedt, G., Woodfall, B., & Picchio, G. (2010) · AIDS · doi:10.1097/qad.0b013e32833677ac · Cited by 185
Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV
Paton, N. I., Musaazi, J., Kityo, C., Walimbwa, S., Hoppe, A., Balyegisawa, A., Kaimal, A., Mirembe, G., Tukamushabe, P., Ategeka, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101609 · Cited by 178
Kuritzkes, D. R., Quinn, J. B., Benoit, S. L., Shugarts, D. L., Griffin, A., Bakhtiari, M., Poticha, D., Eron, J. J., Fallon, M. A., & Rubin, M. (1996) · AIDS · doi:10.1097/00002030-199610090-00007 · Cited by 177
Human Immunodeficiency Virus gag and protease: partners in resistance
Fun, A., Wensing, A. M. J., Verheyen, J., & Nijhuis, M. (2012) · Retrovirology · doi:10.1186/1742-4690-9-63 · Cited by 174
Self-citationRimsky, L., Vingerhoets, J., Van Eygen, V., Eron, J., Clotet, B., Hoogstoel, A., Boven, K., & Picchio, G. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31823df4da · Cited by 173
Fransen, S., Gupta, S., Danovich, R., Hazuda, D., Miller, M., Witmer, M., Petropoulos, C. J., & Huang, W. (2009) · Journal of Virology · doi:10.1128/jvi.01168-09 · Cited by 172
Orkin, C., Squires, K. E., Molina, J.-M., Sax, P. E., Wong, W.-W., Sussmann, O., Kaplan, R., Lupinacci, L., Rodgers, A., Xu, X., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy540 · Cited by 172
Xu, L., Pozniak, A., Wildfire, A., Stanfield-Oakley, S. A., Mosier, S. M., Ratcliffe, D., Workman, J., Joall, A., Myers, R., Smit, E., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1113-1119.2005 · Cited by 166
Hofstra, L. M., Sauvageot, N., Albert, J., Alexiev, I., García, F., Struck, D., van de Vijver, D. A. M. C., Åsjö, B., Beshkov, D., Coughlan, S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ963 · Cited by 160
Self-citationMulti-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance
Rabi, S. A., Laird, G. M., Durand, C. M., Laskey, S. B., Shan, L., Bailey, J. R., Chioma, S., Moore, R. D., & Siliciano, R. F. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67399 · Cited by 159
Harrigan, P. R., Stone, C., Griffin, P., Nájera, I., Bloor, S., Kemp, S., Tisdale, M., Larder, B., & the CNA2001 Investigative Group (2000) · The Journal of Infectious Diseases · doi:10.1086/315317 · Cited by 159
Molina, J., Squires, K., Sax, P. E., Cahn, P. E., Lombaard, J. J., DeJesus, E., Lai, M., Xu, X., Rodgers, A., Lupinacci, L. C., et al. (2018) · The Lancet HIV · doi:10.1016/s2352-3018(18)30021-3 · Cited by 155
A systematic review of the genetic mechanisms of dolutegravir resistance
Rhee, S., Grant, P., Tzou, P. L., Barrow, G., Harrigan, P. R., Ioannidis, J. P. A., & Shafer, R. W. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz256 · Cited by 154
Self-citationWinters, M. A., Shafer, R. W., Jellinger, R. A., Mamtora, G., Gingeras, T., & Merigan, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.757 · Cited by 147
Self-citationOverton, E. T., Richmond, G., Rizzardini, G., Thalme, A., Girard, P.-M., Wong, A., Porteiro, N., Swindells, S., Reynes, J., Noe, S., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad020 · Cited by 145
In Vitro Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor
Lai, M., Feng, M., Falgueyret, J., Tawa, P., Witmer, M. V., DiStefano, D. J., Li, Y., Burch, J. D., Sachs, N. A., Lu, M., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02403-13 · Cited by 143
2019 update of the drug resistance mutations in HIV-1.
Wensing, A. M. J., Cálvez, V., Ceccherini‐Silberstein, F., Charpentier, C., Günthard, H. F., Paredes, R., Shafer, R. W., & Richman, D. D. (2019) · PubMed · Cited by 143
Self-citationNowicka-Sans, B., Gong, Y.-F., McAuliffe, B. V., Dicker, I. B., Ho, H., Zhou, N., Eggers, B. J., Lin, P., Ray, N., Wind‐Rotolo, M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00426-12 · Cited by 139
Marzinke, M. A., Grinsztejn, B. G. J., Fogel, J. M., Piwowar‐Manning, E., Li, M., Weng, L., McCauley, M., Cummings, V., Ahmed, S., Haines, C. D., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab152 · Cited by 136
the Montreal Primary HIV (PHI) Cohort Study Group, Oliveira, M., Ibanescu, R.-I., Anstett, K., Mésplède, T., Routy, J., Robbins, M., & BRENNER, B. G. (2018) · Retrovirology · doi:10.1186/s12977-018-0440-3 · Cited by 128
Abram, M. E., Hluhanich, R. M., Goodman, D. D., Andreatta, K. N., Margot, N., Ye, L., Niedziela‐Majka, A., Barnes, T. L., Novikov, N. Y., Chen, X., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02568-12 · Cited by 121
Feng, M., Wang, D., Grobler, J. A., Hazuda, D. J., Miller, M. D., & Lai, M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04201-14 · Cited by 117
Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
Smith, S. J., Zhao, X. Z., Burke, T. R., & Hughes, S. H. (2018) · Retrovirology · doi:10.1186/s12977-018-0420-7 · Cited by 114
Reeves, J. D., Miamidian, J. L., Biscone, M. J., Lee, F.-H., Ahmad, N., Pierson, T. C., & Doms, R. W. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5476-5485.2004 · Cited by 113
Xu, H., Asahchop, E. L., Oliveira, M., Quashie, P. K., Quan, Y., BRENNER, B. G., & Wainberg, M. A. (2011) · Journal of Virology · doi:10.1128/jvi.05584-11 · Cited by 99
Lataillade, M., Lalezari, J. P., Kozal, M. J., Aberg, J. A., Pialoux, G., Cahn, P. E., Thompson, M., Molina, J., Moreno, S., Grinsztejn, B. G. J., et al. (2020) · The Lancet HIV · doi:10.1016/s2352-3018(20)30240-x · Cited by 98
Kulkarni, R., Babaoglu, K., Lansdon, E. B., Rimsky, L. T., Eygen, V. V., Picchio, G., Svarovskaia, E. S., Miller, M. D., & White, K. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31823aca74 · Cited by 87
Parikh, U. M., Zelina, S., Sluis‐Cremer, N., & Mellors, J. W. (2007) · AIDS · doi:10.1097/qad.0b013e3281ac229b · Cited by 86
Doyle, T., Dunn, D. T., Ceccherini‐Silberstein, F., de Mendoza, C., Garcia, F., Smit, E., Fearnhill, E., Marcelin, A., Martínez‐Picado, J., Kaiser, R., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv243 · Cited by 85
Self-citationPace, C. S., Fordyce, M. W., Franco, D., Kao, C.-Y., Seaman, M. S., & Ho, D. D. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182732746 · Cited by 83
Evolutionary pathways of transmitted drug-resistant HIV-1
Pingen, M., Nijhuis, M., de Bruijn, J. A., Boucher, C. A., & Wensing, A. M. J. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr157 · Cited by 81
Self-citationIsolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen
Friend, J., Parkin, N. T., Liegler, T. J., Martin, J. N., & Deeks, S. G. (2004) · AIDS · doi:10.1097/00002030-200409240-00016 · Cited by 78
Tambuyzer, L., Nijs, S., Daems, B., Picchio, G., & Vingerhoets, J. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182237f74 · Cited by 77
Toma, J., Weinheimer, S. P., Stawiski, E. W., Whitcomb, J. M., Lewis, S. T., Petropoulos, C. J., & Huang, W. (2011) · Journal of Virology · doi:10.1128/jvi.02237-10 · Cited by 73
Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy
Hatano, H., Lampiris, H. W., Fransen, S., Gupta, S., Huang, W., Hoh, R., Martin, J. N., Lalezari, J. P., Bangsberg, D. R., Petropoulos, C. J., et al. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181c42ea4 · Cited by 72
Parikh, U. M., Barnas, D., Faruki, H., & Mellors, J. W. (2006) · The Journal of Infectious Diseases · doi:10.1086/505711 · Cited by 70
Marcelin, A., Charpentier, C., Jary, A., Perrier, M., Margot, N., Callebaut, C., Cálvez, V., & Descamps, D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa060 · Cited by 65
Self-citationDeanda, F., Hightower, K. E., Nolte, R. T., Hattori, K., Yoshinaga, T., Kawasuji, T., & Underwood, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077448 · Cited by 64
Gatell, J. M., Katlama, C., Grinsztejn, B. G. J., Eron, J. J., Lazzarin, A., Vittecoq, D., Gonzalez, C. J., Danovich, R. M., Wan, H. I., Zhao, J., et al. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181c9c967 · Cited by 63
Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study
Margot, N., VanderVeen, L. A., Naik, V., Ram, R. R., Parvangada, P. C., Martin, R., Rhee, M. S., & Callebaut, C. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab503 · Cited by 63
Garcia-Lerma, J. G., MacInnes, H., Bennett, D., Weinstock, H., & Heneine, W. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7545-7552.2004 · Cited by 60
Hu, Z., & Kuritzkes, D. R. (2011) · Journal of Virology · doi:10.1128/jvi.05578-11 · Cited by 59
Rilpivirine and Doravirine Have Complementary Efficacies Against NNRTI-Resistant HIV-1 Mutants
Smith, S. J., Pauly, G. T., Akram, A., Melody, K., Ambrose, Z., Schneider, J. P., & Hughes, S. H. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001031 · Cited by 59
Armenia, D., Vandenbroucke, I., Fabeni, L., Marck, H. G. V., Cento, V., D’Arrigo, R., Wesenbeeck, L. V., Scopelliti, F., Micheli, V., Bruzzone, B. M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir821 · Cited by 54
Self-citationMalet, I., Arriaga, L. G., Artese, A., Costa, G., Parrotta, L., Alcaro, S., Delelis, O., Tmeizeh, A., Katlama, C., Valantin, M., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku095 · Cited by 51
Self-citationReview of Doravirine Resistance Patterns Identified in Participants During Clinical Development
Martin, E. A., Lai, M., Ngo, W., Feng, M., Graham, D. J., Hazuda, D. J., Kumar, S., Hwang, C. K., Sklar, P. A., & Asante‐Appiah, E. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002496 · Cited by 49
Kuritzkes, D. R., Bassett, R. L., Hazelwood, J. D., et al. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200405010-00008 · Cited by 48
von Wyl, V., Yerly, S., Böni, J., Bürgisser, P., Klimkait, T., Battegay, M., Bernasconi, E., Cavassini, M. L., Furrer, H., Hirschel, B. J., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/528863 · Cited by 48
Self-citationSuccessful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study
Scherrer, A., Yang, W.-L., Kouyos, R. D., Böni, J., Yerly, S., Klimkait, T., Aubert, V., Cavassini, M. L., Battegay, M., Hauser, C., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw165 · Cited by 45
Self-citationSeki, T., Suyama, A., Kawauchi, S., Miki, S., Wakasa-Morimoto, C., Akihisa, E., Nakahara, K., Kobayashi, M., Underwood, M., Sato, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04844-14 · Cited by 44
Gupta, S., Vingerhoets, J., Fransen, S., Tambuyzer, L., Azijn, H., Frantzell, A., Paredes, R., Coakley, E. P. G., Nijs, S., Clotet, B., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01695-10 · Cited by 37
Self-citationPicchio, G., Rimsky, L. T., Eygen, V. V., Haddad, M., Napolitano, L. A., & Vingerhoets, J. (2013) · Antiviral Therapy · doi:10.3851/imp2771 · Cited by 30
Chamberlain, N., Mena, L. A., & Brock, J. B. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab297 · Cited by 26
Cheung, P. K., Shahid, A., Dong, W. W. Y., Lepik, K. J., Montaner, J. S. G., Brockman, M. A., Brumme, Z. L., & Brumme, C. J. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab498 · Cited by 15
Chunduri, H., Crumpacker, C. S., & Sharma, P. L. (2011) · Virology · doi:10.1016/j.virol.2011.03.007 · Cited by 13
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Massively multiplexed nucleic acid detection with Cas13
Ackerman, C. M., Myhrvold, C., Thakku, S. G., Freije, C. A., Metsky, H. C., Yang, D. K., Ye, S. H., Boehm, C. K., Kosoko-Thoroddsen, T.-S. F., Kehe, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2279-8 · Cited by 803
Cahn, P., Madero, J. S., Arribas, J. R., Antinori, A., Ortiz, R., Clarke, A. E., Hung, C.-C., Rockstroh, J. K., Girard, P.-M., Sievers, J., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32462-0 · Cited by 387
HIV-1 drug resistance and resistance testing
Clutter, D. S., Jordan, M. R., Bertagnolio, S., & Shafer, R. W. (2016) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2016.08.031 · Cited by 333
Self-citationvan Wyk, J., Ajana, F., Bisshop, F., De Wit, S., Osiyemi, O., Portilla Sogorb, J., Routy, J.-P., Wyen, C., Ait-Khaled, M., Nascimento, M. C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1243 · Cited by 282
Metadata
- Authors
- Wensing, A. M. J., Cálvez, V., Ceccherini‐Silberstein, F., Charpentier, C., Günthard, H. F., Jacobsen, D. M., Paredes, R., Shafer, R. W., & Richman, D. D.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2015-11-01
- Volume
- 22
- Issue
- 3
- Pages
- 132-41
- OpenAlex
- W2187165435
- Cited by
- 415
- References
- 87
- FWCI
- 53.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.